InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-30.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Cavanaugh Stefanie L., 首席财务官. Director active across 3 companies, notably Apollo Endosurgery, Inc.. Aggregated, 9 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 7 July 2021. The latest transaction was filed on 4 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cavanaugh Stefanie L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
5,937 股0Common StockSEC:0001641172-25-013811:0
5,938 股0Common StockSEC:0001641172-25-002184:0
5,937 股0Common StockSEC:0001688530-25-000001:0
5,938 股0Common StockSEC:0001688530-24-000002:0
16,804 股0Common StockSEC:0000950170-24-096254:0
3,268 股Common StockSEC:0001688530-24-000001:0
6,281 股@ US$3.98100.0% 占其流量Common stockSEC:0001688530-23-000002:0
标准退出：2023年10月22日 (T+90)
28,623 股0Common StockSEC:0001688530-23-000001:0
91 股0Common StockSEC:0001251769-21-000092:0
9 条申报中的 9 条
About Cavanaugh Stefanie L.
Stefanie L. Cavanaugh is Directeur Financier and also serves as Director at Aspira Women's Health Inc. and as CFO, Treasurer, Secretary at Apollo Endosurgery, Inc. She has 9 filings in total, and among the recent sampled filings the period runs from 2021-07-07 to 2025-06-05, with EUR 22596 of buys and EUR 0 of sells, and the most frequent transaction nature being Levée d'options.
